I think we'll get more info than that Pete. Interim data on other bio's that were double blind first reported that the mid stage has been reached and then usually 3 weeks give or take (after data collection, which puts Sept. 1st right on time for our Q3 data) we see top line data, SAE's and response, how many did what mg and if any dropped out. Similar to an un-blinded. IPIX just reported the trial has finished recruiting, exceeding the number aimed for. I expect that they will soon change the trial to Active, not recruiting, this may or may not be one of the rules to continue blinded.

All imo